Bone mineral density and bone metabolism in patients with major depressive disorder without somatic comorbidities

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 44, Issue , 2013, Pages 58-63

  Malik, P ^a   Gasser, R W ^b   Moncayo, R C ^a   Kandler, C ^a   Koudouovoh Tripp, P ^a   Giesinger, J ^a   Sperner Unterweger, B ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Bone formation; Bone mineral density; IPAQ; Major depressive disorder; Osteoprotegerin

Indexed keywords

C REACTIVE PROTEIN; ESTRADIOL; INTERLEUKIN 6; OSTEOCALCIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; PROLACTIN; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE METABOLISM; CLINICAL ARTICLE; COMORBIDITY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HIGH RISK POPULATION; HUMAN; MAJOR DEPRESSION; MALE; OSTEOPENIA; OSTEOPOROSIS; PHYSICAL ACTIVITY; RISK ASSESSMENT; SMOKING;

ABSORPTIOMETRY, PHOTON; ADULT; BODY MASS INDEX; BONE AND BONES; BONE DENSITY; CYTOKINES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; METABOLIC DISEASES; MIDDLE AGED; OSTEOPROTEGERIN; YOUNG ADULT;

EID: 84874354968     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.01.019     Document Type: Article

References (46)

1. Amsterdam J.D., Hooper M.B. Bone density measurement in major depression. Prog Neuropsychopharmacol Biol Psychiatry 1998, 22:267-277.
2. Aydin H., Mutlu N., Akbas N.B. Treatment of a major depression episode suppresses markers of bone turnover in premenopausal women. J Psychiatr Res 2011, 45:1316-1320.
3. Berk M., Sanders K.M., Pasco J.A., Jacka F.N., Williams L.J., Hayles A.L., et al. Vitamin D deficiency may play a role in depression. Med Hypotheses 2007, 69:1316-1319.
4. Borer K.T. Physical activity in the prevention and amelioration of osteoporosis in women: interaction of mechanical, hormonal and dietary factors. Sports Med 2005, 35:779-830.
5. Camacho T.C., Roberts R.E., Lazarus N.B., Kaplan G.A., Cohen R.D. Physical activity and depression: evidence from the Alameda County Study. Am J Epidemiol 1991, 134:220-231.
6. Cauley J.A., Fullman R.L., Stone K.L., Zmuda J.M., Bauer D.C., Barrett-Connor E., et al. Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int 2005, 16:1525-1537.
7. Chakkalakal D.A. Alcohol-induced bone loss and deficient bone repair. Alcohol Clin Exp Res 2005, 29:2077-2090.
8. Cizza G., Primma S., Coyle M., Gourgiotis L., Csako G. Depression and osteoporosis: a research synthesis with meta-analysis. Horm Metab Res 2010, 42:467-482.
9. Dargent-Molina P., Poitiers F., Bréart G. In elderly women weight is the best predictor of a very low bone mineral density: evidence from the EPIDOS study. Osteoporos Int 2000, 11:881-888. EPIDOS Group.
10. Diem S.J., Blackwell T.L., Stone K.L., Yaffe K., Haney E.M., Bliziotes M.M., et al. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 2007, 25167:240-245.
11. Diem S.J., Harrison S.L., Haney E., Cauley J.A., Stone K.L., Orwoll E., Ensrud K.E. Osteoporotic Fractures in Men (MrOS) Research Group, Depressive symptoms and rates of bone loss at the hip in older men. Osteoporos Int 2013 Jan, 24(1):111-119.
12. Ershler W.B., Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000, 51:245-270.
13. Eskandari F., Martinez P.E., Torvik S., Phillips T.M., Sternberg E.M., Mistry S., et al. Low bone mass in premenopausal women with depression. Arch Intern Med 2007, 167:2329-2336.
14. Haney E.M., Chan B.K., Diem S.J., Ensrud K.E., Cauley J.A., Barrett-Connor, et al. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 2007, 167:1246-1251.
15. Ho A.Y., Kung A.W. Determinants of peak bone mineral density and bone area in young women. J Bone Miner Metab 2005, 23:470-475.
16. Holickm M.F. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009, 19:73-78.
17. Hope S., Melle I., Aukrust P., Agartz I., Lorentzen S., Steen N.E., et al. Osteoprotegerin levels in patients with severe mental disorders. J Psychiatry Neurosci 2010, 35:304-310.
18. Hopper J.L., Seeman E. The bone density of female twins discordant for tobacco use. N Engl J Med 1994, 330:387-392.
19. Jefferson A.L., Massaro J.M., Wolf P.A., Seshadri S., Au R., Vasan R.S., et al. Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study. Neurology 2007, 68:1032-1038.
20. Kahl K.G., Rudolf S., Dibbelt L., Stoeckelhuber B.M., Gehl H.B., Hohagen F., et al. Decreased osteoprotegerin and increased bone turnover in young female patients with major depressive disorder and a lifetime history of anorexia nervosa. Osteoporos Int 2005, 16:424-429.
21. Kahl K.G., Greggersen W., Rudolf S., Stoeckelhuber B.M., Bergmann-Koester C.U., Dibbelt L., et al. Bone mineral density, bone turnover, and osteoprotegerin in depressed women with and without borderline personality disorder. Psychosom Med 2006, 68:669-674.
22. Kapoor D., Jones T.H. Smoking and hormones in health and endocrine disorders. Eur J Endocrinol 2005, 152:491-499.
23. Kavuncu V., Kuloglu M., Kaya A., Sahin S., Atmaca M., Firidin B. Bone metabolism and bone mineral density in premenopausal women with mild depression. Yonsei Med J 2002, 43:101-108.
24. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105.
25. Kinjo M., Setoguchi S., Schneeweiss S., Solomon D.H. Bone mineral density in subjects using central nervous system-active medications. Am J Med 2005, 118:1414.e7-1414.e12.
26. Korpelainen R., Korpelainen J., Heikkinen J., Väänänen K., Keinänen-Kiukaanniemi S. Lifelong risk factors for osteoporosis and fractures in elderly women with low body mass index-a population-based study. Bone 2006, 39:385-391.
27. Malik P., Gasser R.W., Kemmler G., Moncayo R., Finkenstedt G., Kurz M., et al. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study. Alcohol Clin Exp Res 2009, 33:375-381.
28. Marques-Deak A., Cizza G., Sternberg E. Brain-immune interactions and disease susceptibility. Mol Psychiatry 2005, 10:239-250.
29. Michelson D., Stratakis C., Hill L., Reynolds J., Galliven E., Chrousos G., et al. Bone mineral density in women with depression. N Engl J Med 1996, 335:1176-1181.
30. Moldin S.O., Scheftner W.A., Rice J.P., Nelson E., Knesevich M.A., Akiskal H. Association between major depressive disorder and physical illness. Psychol Med 1993, 23:755-761.
31. Petronijević M., Petronijević N., Ivković M., Stefanović D., Radonjić N., Glisić B., et al. Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression. Bone 2008, 42:582-590.
32. Ravn P., Cizza G., Bjarnason N.H., Thompson D., Daley M., Wasnich R.D., et al. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. J Bone Miner Res 1999, 14:1622-1627.
33. Reginste J.Y., Deroisy R., Paul I., Hansenne M., Ansseau M. Depressive vulnerability is not an independent risk factor for osteoporosis in postmenopausal women. Maturitas 1999, 33:133-137.
34. Schweiger U., Deuschlem M., Körner A., Lammers C.H., Schmider J., Gotthardt U., et al. Low lumbar bone mineral density in patients with major depression. Am J Psychiatry 1994, 151:1691-1693.
35. Søgaard A.J., Joakimsen R.M., Tverdal A., Fønnebø V., Magnus J.H., Berntsen G.K. Long-term mental distress, bone mineral density and non-vertebral fractures. The Tromsø Study. Osteoporos Int 2005, 16:887-897.
36. Theoleyre S., Wittrant Y., Tat S.K., Fortun Y., Redini F., Heymann D. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 2004, 15:457-475.
37. Trouvin A.P., Goëb V. Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss. Clin Interv Aging 2010, 5:345-354.
38. Tsapakis E.M., Gamie Z., Tran G.T., Adshead S., Lampard A., Mantalaris A., et al. The adverse skeletal effects of selective serotonin reuptake inhibitors. Eur Psychiatry 2012, 27:156-169.
39. Ueland T., Bollerslev J., Godang K., Müller F., Frøland S.S., Aukrust P. Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess-possible role in bone homeostasis. Eur J Endocrinol 2001, 145:685-690.
40. Whooley M.A., Kip K.E., Cauley J.A., Ensrud K.E., Nevitt M.C., Browner W.S. Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1999, 159:484-490.
41. Whooley M.A., Cauley J.A., Zmuda J.M., Haney E.M., Glynn N.W. Depressive symptoms and bone mineral density in older men. J Geriatr Psychiatry Neurol 2004, 17:88-92.
42. Williams L.J., Henry M.J., Berk M., Dodd S., Jacka F.N., Kotowicz M.A., et al. Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. Int Clin Psychopharmacol 2008, 23:84-87.
43. Wu Q., Bencaz A.F., Hentz J.G., Crowell M.D. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies. Osteoporos Int 2012, 23:365-375.
44. Yadav V.K., Ryu J.H., Suda N., Tanaka K.F., Gingrich J.A., Schütz G., et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum: an entero-bone endocrine axis. Cell 2008, 28:825-837.
45. Yazici A.E., Bagis S., Tot S., Sahin G., Yazici K., Erdogan C. Bone mineral density in premenopausal women with major depression. Joint Bone Spine 2005, 72:540-543.
46. Yirmiya R., Bab I. Major depression is a risk factor for low bone mineral density: a meta-analysis. Biol Psychiatry 2009, 66:423-442.